Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:02:11.297Z.
Consensus retrieved: 2026-10-06T10:40:15.583Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:02:11.297Z.
Quote observation: 2026-10-06T14:57:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e7a9a1b17caad0ab37430e79e816a911291535ac0fb348029df9f580b63ef335
Forward PE Ratio (N/A) = Dated Quote Price ($0.94) / Consensus Forward EPS ($-3.86)
FORWARD PE RATIO
N/A
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.35M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.35M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.28M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.40M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.46M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.47M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.94M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.94, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-3.86 | $-3.92 – $-3.76 | 2 | n/m |
| 2027-12-31 | $-3.01 | $-3.55 – $-2.21 | 2 | n/m |
| 2028-12-31 | $-1.85 | $-1.92 – $-1.78 | 2 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
